Hubei Minkang Pharmaceutical Ltd. - FORM 8-K - May 15, 2012

Attached files

file filename
EX-99.1 - PRESS RELEASE - Hubei Minkang Pharmaceutical Ltd.ex99-1.htm
EX-10.1 - LOAN CONTRACT - Hubei Minkang Pharmaceutical Ltd.ex10-1.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 8-K

 

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934







Date of Report (Date of earliest event reported) May 7, 2012




 





HUBEI MINKANG PHARMACEUTICAL LTD.

(Exact name of registrant as specified in its charter)




 





Nevada

(State or other jurisdiction 

of incorporation



000-53231

(Commission 

File Number)



26-2410685

(IRS Employer 

Identification No.)















55 Ubi Ave. 3, #03-01, Mintwell Building

Singapore

(Address of principal executive offices)



408864

(Zip Code)













 
 














Registrant's telephone number, including area code   +65-6747-7883















N/A

(Former name or former address, if changed since last report)




 
 










Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:




[ ]       Written communications pursuant to Rule 425 under the Securities Act

           (17 CFR 230.425)




[ ]       Soliciting material pursuant to Rule 14a-12 under the Exchange Act

           (17 CFR 240.14a-12)




[ ]       Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

           (17 CFR 240.14d-2(b))




[ ]       Pre-commencement communications pursuant to Rule 13e-4© under the Exchange Act

           (17 CRF 240.13e-4(c))




SECTION 1 - REGISTRANT'S BUSINESS AND OPERATIONS




Item 1.01  Entry into a Material Definitive Agreement




On May 7, 2012, our indirect wholly-owned subsidiary, Hubei Minkang Pharmaceutical Co., Ltd. ("Hubei Minkang PRC"), and Bank of Communications Co., Ltd., Yichang Branch, ("Bank of Communications") executed a loan contract (the "Loan Contract"), where Hubei Minkang PRC loaned RMB 10,000,000 to be used as liquidity, with a loan period from May 7, 2012 to May 7, 2013 and having an interest rate of 7.872% per annum, which is calculated and paid on the 20th of each month, with principal due May 7, 2013.




The foregoing description of Loan Contract does not purport to be complete and is qualified in its entirety by reference to the Loan Contract, which is filed as Exhibit 10.1 hereto, and is incorporated by reference herein.




The Loan Contract is secured by the same two maximum pledge contracts (collectively, the "Maximum Pledge Contracts"), dated January 13, 2011 and May 1, 2011, respectively, between Hubei Minkang PRC and Bank of Communications.  Under the Maximum Pledge Contracts, the Loan Contract is collateralized by certain of Hubei Minkang PRC's buildings and land use rights.




The foregoing description of the Maximum Pledge Contracts do not purport to be complete and are qualified in their entirety by reference to the Maximum Pledge Contracts, which were filed as Exhibits 10.7 ad 10.8 to our Current Report on Form 8-K filed on September 26, 2011, and are incorporated by reference herein.




 


SECTION 2 - FINANCIAL INFORMATION




Item 2.03  Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant




The disclosure under Item 1.01 of this Current Report on Form 8-K is responsive to this item and is incorporated by reference herein. 




 


SECTION 7 - REGULATION FD




Item 7.01  Regulation FD Disclosure




On May 15, 2012, we issued a press release about the closing of a recent private placement involving the sale of 1,130,270 shares of our common stock at a price of $0.70 per share for gross proceeds of $791,189.




A copy of the press release is attached as Exhibit 99.1 hereto.




 


SECTION 9 - FINANCIAL STATEMENTS AND EXHIBITS




Item 9.01  Financial Statements and Exhibits




          (a)   Financial Statements of Business Acquired.




Not applicable.




          (b)   Pro Forma Financial Information.




Not applicable.




          (c)   Shell Company Transactions.




Not applicable.








          (d)   Exhibits.








Exhibit No.



Description of Exhibit






10.1



Loan Contract, dated May 7, 2012, among Hubei Minkang Pharmaceutical Co., Ltd. and Bank of Communications Co., Ltd., Yichang Branch, for RMB 10,000,000.






99.1



Press Release dated May 15, 2012.









 


 


 






SIGNATURES




Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. 


Date: May 15, 2012






Hubei Minkang Pharmaceutical Ltd.












By:



 



/s/ Grace Ang






Name:



 



Grace Ang






Title:



 



Secretary, Treasurer and Director











 

								
								
							 

                     
						

                     

                     
                     

                                                        
							
							

                                                        




                                                        
			 
                        

                           
Hubei Minkang Pharmaceutical Ltd. Reports

                           
                        

                                                
						




			 
                        

                           
Also read